LoneStar AgriTech is the agricultural sister company to LoneStar Medtech. AgriTech is designed to grow all of the raw material extraction products like hops (for beer and medicinal extracts) and cannabis (hemp and marijuana extracts with medicinal cannabinoids). Even though these medicinal extracts seem "new" to us, they have been used for over 10,000 years and are making a huge comeback. Natural phytobiotic medicines are changing the way patients look at natural alternatives to big pharma.
The largest group of investors for LoneStar Life Sciences is TexMed Ventures, a Texas doctor owned investment group. Doctors are frustrated with the current state of American healthcare. Patients are looking for natural alternatives to big pharma. While the FDA continues to restrict the advancement of natural therapies that work in harmony with the body's natural ability to heal itself, forward thinking TexMed Ventures no longer wants to be part of the problem, that want to create the solution.
As a co-founder and Chief Medical Officer of LoneStar Life Sciences, former President of the American Heart Association, and the managing partner for TexMed Ventures LLC, Jude sees the potential future of a new market - the natural alternative to big pharma, and a broader option for patient choice. Dr Espinoza shares his personal experience and excitement about natural therapies like Xanthohumol and CBD - the two core compounds in XanthoCanna.
Dr Duke discusses pain management and the failure of opioid therapy. In the US, opioid addiction is now the new gateway drug and kills an average of 130 Americans per day. Natural therapies like phytobiotics have proven to be the "exit drug" for the opioid epidemic, and Dr Duke sees natural alternatives as the future for safer and more effective therapy. In fact, in the states medical cannabis has been legalized, there has been a 33% reduction in opioid overdose deaths in those states.
As the American population becomes older, pain management in geriatrics becomes critically important as a natural alternative to opioid prescriptions. Dr Castillo offers a few comments about why he invested into TexMed Ventures to support LoneStar Life Sciences and LoneStar MedTech in the development of natural alternatives to big pharma.
Matt Atwood speaks to 500 doctors at the Winter session for Texas Osteopathic Medical Association in January 2019 about medical cannabis in Texas. After the seminar, about 30% of the doctors followed Matt out of the speaking arena to ask more questions. LoneStar MedTech looks at Xanthohumol and CBD as an "OTC" or over the counter product while THC should be prescribed "behind the counter" by a licensed doctor.
LoneStar Life Sciences visited Hawaii to present a program we developed for the Aloha State. The program was a $10M project which included a large greenhouses for year round grow of hops, hemp and food crops on the island, extraction facilit. The agriculture in Hawaii has all but shut down due to the high cost of living in Hawaii. Our program included affordable 3D printed homes from hemp-create and solar powered roof tops to generate renewable energy sources that could withstand tropical storms
The launch of our own MD420 magazine. MD420 was designed to discuss political facts vs fiction, and medical proof over stigma. This will be something we will continue once we establish a foothold with XanthoCanna. Our plan is to establish a MD420 Podcast to interview politicians, doctors, researchers, hemp processing experts, commercial hemp manufacturers and patient testimonials.
Another morning show interview on MD420.